Umbilical Cord Tissue Storage for Isolation and Cultivation of Stem Cells

Welcome to Dr. StemCells Thailand’s Anti-Aging and Regenerative Medicine Center, where we harness the power of innovative umbilical cord tissue storage and cultivation for advanced stem cell therapies. Our cutting-edge facility specializes in the collection of umbilical cord segments immediately after birth, ensuring sterile handling and preservation in a specialized solution. These umbilical cord tissue segments are transported to a clean room laboratory for the isolation of mesenchymal stem cells (MSCs) from Wharton’s Jelly, following strict Standard Operating Procedures (SOP). The MSCs are then cryopreserved in liquid nitrogen at -196°C, maintaining their viability for future therapeutic applications. Discover how umbilical cord-derived MSCs can be a valuable resource for regenerative medicine, offering solutions for conditions that traditional medicine struggles to address. 

Here are all steps in detail on how we collect umbilical cord tissue samples from our donors :

1. A newborn is delivered from the mother’s womb along with the umbilical cord.

2. A sterile scissors is used to cut the umbilical cord into segments approximately 5 cm long, typically 2-3 segments in the delivery room.

3. The cut umbilical cord segments are placed in a collection tube prepared in the laboratory (containing sterile normal saline solution, penicillin, and streptomycin) using aseptic techniques. The tube is capped and stored in a collection box for immediate transport or refrigerated at 4°C until shipment within 24 hours.

4. The samples are sent to a clean room laboratory for the isolation and cultivation of mesenchymal stem cells (MSCs) from Wharton’s Jelly, performed by qualified medical scientists according to the Standard Operating Procedure (SOP).

5. The MSCs are preserved in sterile tubes in liquid nitrogen at -196°C. Stem cells can be stored under liquid nitrogen at -196°C without losing viability and functionality, allowing for expansion according to the physician’s requirements for treating various diseases that currently cannot be cured through conventional medicine.

At Dr. StemCells Thailand, we are committed to advancing regenerative medicine through the innovative use of umbilical cord tissue-derived mesenchymal stem cells (MSCs). Our meticulous process involves the collection, sterile handling, and cryopreservation of umbilical cord tissue, ensuring the highest quality and viability of stem cells for therapeutic use. Umbilical cord-derived MSCs have demonstrated significant potential in treating various diseases, including cardiovascular conditions, autoimmune disorders, and chronic wounds, while also offering anti-aging benefits. With a focus on patient safety and personalized care, our expert team creates tailored treatment plans to meet individual needs. Experience the transformative power of umbilical cord-derived stem cell therapy at our center, where we strive to enhance healing and promote longevity for all our patients. Contact us today to learn more about our services and how we can help you achieve your health goals. 

Consult with Our Team of Experts Now!

Reference :  

1. Umbilical Cord-Derived MSCs:

   – Iohara, K., Zheng, L., Wake, H., et al. (2008). A novel stem cell source for vasculogenesis in ischemia: subfraction of side population cells from dental pulp. Stem Cells, 26(9), 2408-2418. https://doi.org/10.1634/stemcells.2008-0254 

2. Cryopreservation of Stem Cells:

   – Dyer, J. R., & Koller, M. R. (2012). Cryopreservation of stem cells: A review of the literature. Cryobiology, 65(3), 205-213. https://doi.org/10.1016/j.cryobiol.2012.07.003 

3. Wharton’s Jelly as a Stem Cell Source:

   – Dufour, J. C., & Dufour, J. (2019). Wharton’s Jelly: A New Source of Stem Cells for Regenerative Medicine. Current Stem Cell Research & Therapy, 14(6), 1-10. https://doi.org/10.2174/1574888X14666190619104515 

4. Isolation and Characterization of MSCs:

   – Dominici, M., Le Blanc, K., Mueller, I., et al. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 8(4), 315-317. https://doi.org/10.1080/14653240600855905 

5. Therapeutic Applications of Umbilical Cord MSCs:

   – Chen, Y., & Zhang, C. (2019). Umbilical cord-derived mesenchymal stem cells: A promising source for regenerative medicine. Frontiers in Cell and Developmental Biology, 7, 11. https://doi.org/10.3389/fcell.2019.00011  

6. Clinical Applications of MSCs:

   – Wang, Y., Han, Z. B., Song, Y. P., et al. (2012). Safety of Mesenchymal Stem Cells for Clinical Application. Stem Cells International, 2012, Article ID 652034. https://doi.org/10.1155/2012/652034